APO RESEARCH · REPORT
Women's Health
This report focuses on pharmaceutical products for female-related diseases.
Product & engineering
Understand the product.
This report focuses on pharmaceutical products for female-related diseases.
Selected research
Market Structure
Global Women's Health Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
This report focuses on pharmaceutical products for female-related diseases.
The main companies of Global Women's Health include Amgen, Bayer, Merck KGaA, etc. These top three companies hold a market share about 20%. Europe and North America are the leading production regions in the world. The product is mainly used in contraceptive pills.
Report Includes
Read the full market overview
This report provides an overview of the global Women's Health market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Women's Health and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Women's Health revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Women's Health market size, projected growth trends, production technologies, key applications, and end-use industries.
Women's Health Segment by Company
Amgen
Bayer
Merck KGaA
Merck & Co
Ferring
Eli Lilly
Pfizer
AbbVie
Abbott
Theramex
Livzon Pharmaceutical Group
Foundation Consumer Healthcare
Zhejiang Xianju Pharmaceutical
Zizhu Pharmaceutical
Qianjin Pharmaceutical
Women's Health Segment by Type
Hormone Therapy
Nonhormonal Therapy
Women's Health Segment by Application
Climacteric
Postmenopausal Osteoporosis
Contraceptive Pill
Infertility
Others
Women's Health Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Women's Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Women's Health and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Women's Health.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Women's Health in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Women's Health industry.
Chapter 3: Detailed analysis of Women's Health companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Women's Healthrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hormone Therapy
- Nonhormonal Therapy
Applications
- Climacteric
- Postmenopausal Osteoporosis
- Contraceptive Pill
- Infertility
- Others
Companies covered
- Amgen
- Bayer
- Merck KGaA
- Merck & Co
- Ferring
- Eli Lilly
- Pfizer
- AbbVie
- Abbott
- Theramex
- Livzon Pharmaceutical Group
- Foundation Consumer Healthcare
- Zhejiang Xianju Pharmaceutical
- Zizhu Pharmaceutical
- Qianjin Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Women's Health Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Hormone Therapy
- 1.2.3 Nonhormonal Therapy
- 1.3 Market Analysis by Application
- 1.3.1 Global Women's Health Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Climacteric
- 1.3.3 Postmenopausal Osteoporosis
- 1.3.4 Contraceptive Pill
- 1.3.5 Infertility
- 1.3.6 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Women's Health Growth Trends by Region
- 1.5.1 Global Women's Health Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Women's Health Market Size by Region (2021-2026)
- 1.5.3 Women's Health Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Women's Health Market Dynamics
- 2.1 Women's Health Industry Trends
- 2.2 Women's Health Industry Drivers
- 2.3 Women's Health Industry Opportunities and Challenges
- 2.4 Women's Health Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Women's Health Revenue by Company (2021-2026)
- 3.2 Global Women's Health Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Women's Health Key Company Head office and Area Served
- 3.4 Global Women's Health Company, Product Type & Application
- 3.5 Global Women's Health Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Women's Health Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Women's Health Players Market Share by Revenue in 2025
- 3.6.3 2025 Women's Health Tier 1, Tier 2, and Tier 3
4 Women's Health Market by Type
- 4.1 Global Women's Health Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Women's Health Market Size by Type (2021-2032)
- 4.3 Global Women's Health Market Size Share by Type (2021-2032)
5 Women's Health Market by Application
- 5.1 Global Women's Health Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Women's Health Market Size by Application (2021-2032)
- 5.3 Global Women's Health Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Amgen
- 6.1.1 Amgen Company Information
- 6.1.2 Amgen Business Overview
- 6.1.3 Amgen Women's Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Amgen Women's Health Product Portfolio
- 6.1.5 Amgen Recent Developments
- 6.2 Bayer
- 6.2.1 Bayer Company Information
- 6.2.2 Bayer Business Overview
- 6.2.3 Bayer Women's Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Bayer Women's Health Product Portfolio
- 6.2.5 Bayer Recent Developments
- 6.3 Merck KGaA
- 6.3.1 Merck KGaA Company Information
- 6.3.2 Merck KGaA Business Overview
- 6.3.3 Merck KGaA Women's Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Merck KGaA Women's Health Product Portfolio
- 6.3.5 Merck KGaA Recent Developments
- 6.4 Merck & Co
- 6.4.1 Merck & Co Company Information
- 6.4.2 Merck & Co Business Overview
- 6.4.3 Merck & Co Women's Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Merck & Co Women's Health Product Portfolio
- 6.4.5 Merck & Co Recent Developments
- 6.5 Ferring
- 6.5.1 Ferring Company Information
- 6.5.2 Ferring Business Overview
- 6.5.3 Ferring Women's Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Ferring Women's Health Product Portfolio
- 6.5.5 Ferring Recent Developments
- 6.6 Eli Lilly
- 6.6.1 Eli Lilly Company Information
- 6.6.2 Eli Lilly Business Overview
- 6.6.3 Eli Lilly Women's Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Eli Lilly Women's Health Product Portfolio
- 6.6.5 Eli Lilly Recent Developments
- 6.7 Pfizer
- 6.7.1 Pfizer Company Information
- 6.7.2 Pfizer Business Overview
- 6.7.3 Pfizer Women's Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Pfizer Women's Health Product Portfolio
- 6.7.5 Pfizer Recent Developments
- 6.8 AbbVie
- 6.8.1 AbbVie Company Information
- 6.8.2 AbbVie Business Overview
- 6.8.3 AbbVie Women's Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 AbbVie Women's Health Product Portfolio
- 6.8.5 AbbVie Recent Developments
- 6.9 Abbott
- 6.9.1 Abbott Company Information
- 6.9.2 Abbott Business Overview
- 6.9.3 Abbott Women's Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Abbott Women's Health Product Portfolio
- 6.9.5 Abbott Recent Developments
- 6.10 Theramex
- 6.10.1 Theramex Company Information
- 6.10.2 Theramex Business Overview
- 6.10.3 Theramex Women's Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Theramex Women's Health Product Portfolio
- 6.10.5 Theramex Recent Developments
- 6.11 Livzon Pharmaceutical Group
- 6.11.1 Livzon Pharmaceutical Group Company Information
- 6.11.2 Livzon Pharmaceutical Group Business Overview
- 6.11.3 Livzon Pharmaceutical Group Women's Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Livzon Pharmaceutical Group Women's Health Product Portfolio
- 6.11.5 Livzon Pharmaceutical Group Recent Developments
- 6.12 Foundation Consumer Healthcare
- 6.12.1 Foundation Consumer Healthcare Company Information
- 6.12.2 Foundation Consumer Healthcare Business Overview
- 6.12.3 Foundation Consumer Healthcare Women's Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Foundation Consumer Healthcare Women's Health Product Portfolio
- 6.12.5 Foundation Consumer Healthcare Recent Developments
- 6.13 Zhejiang Xianju Pharmaceutical
- 6.13.1 Zhejiang Xianju Pharmaceutical Company Information
- 6.13.2 Zhejiang Xianju Pharmaceutical Business Overview
- 6.13.3 Zhejiang Xianju Pharmaceutical Women's Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Zhejiang Xianju Pharmaceutical Women's Health Product Portfolio
- 6.13.5 Zhejiang Xianju Pharmaceutical Recent Developments
- 6.14 Zizhu Pharmaceutical
- 6.14.1 Zizhu Pharmaceutical Company Information
- 6.14.2 Zizhu Pharmaceutical Business Overview
- 6.14.3 Zizhu Pharmaceutical Women's Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Zizhu Pharmaceutical Women's Health Product Portfolio
- 6.14.5 Zizhu Pharmaceutical Recent Developments
- 6.15 Qianjin Pharmaceutical
- 6.15.1 Qianjin Pharmaceutical Company Information
- 6.15.2 Qianjin Pharmaceutical Business Overview
- 6.15.3 Qianjin Pharmaceutical Women's Health Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Qianjin Pharmaceutical Women's Health Product Portfolio
- 6.15.5 Qianjin Pharmaceutical Recent Developments
7 North America
- 7.1 North America Women's Health Market Size (2021-2032)
- 7.2 North America Women's Health Market Size by Type
- 7.2.1 North America Women's Health Market Size by Type (2021-2026)
- 7.2.2 North America Women's Health Market Size by Type (2027-2032)
- 7.2.3 North America Women's Health Market Share by Type (2021-2032)
- 7.3 North America Women's Health Market Size by Application
- 7.3.1 North America Women's Health Market Size by Application (2021-2026)
- 7.3.2 North America Women's Health Market Size by Application (2027-2032)
- 7.3.3 North America Women's Health Market Share by Application (2021-2032)
- 7.4 North America Women's Health Market Size by Country
- 7.4.1 North America Women's Health Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Women's Health Market Size by Country (2021-2026)
- 7.4.3 North America Women's Health Market Size by Country (2027-2032)
- 7.4.4 North America Women's Health Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Women's Health Market Size (2021-2032)
- 8.2 Europe Women's Health Market Size by Type
- 8.2.1 Europe Women's Health Market Size by Type (2021-2026)
- 8.2.2 Europe Women's Health Market Size by Type (2027-2032)
- 8.2.3 Europe Women's Health Market Share by Type (2021-2032)
- 8.3 Europe Women's Health Market Size by Application
- 8.3.1 Europe Women's Health Market Size by Application (2021-2026)
- 8.3.2 Europe Women's Health Market Size by Application (2027-2032)
- 8.3.3 Europe Women's Health Market Share by Application (2021-2032)
- 8.4 Europe Women's Health Market Size by Country
- 8.4.1 Europe Women's Health Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Women's Health Market Size by Country (2021-2026)
- 8.4.3 Europe Women's Health Market Size by Country (2027-2032)
- 8.4.4 Europe Women's Health Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Women's Health Market Size (2021-2032)
- 9.2 China Women's Health Market Size by Type
- 9.2.1 China Women's Health Market Size by Type (2021-2026)
- 9.2.2 China Women's Health Market Size by Type (2027-2032)
- 9.2.3 China Women's Health Market Share by Type (2021-2032)
- 9.3 China Women's Health Market Size by Application
- 9.3.1 China Women's Health Market Size by Application (2021-2026)
- 9.3.2 China Women's Health Market Size by Application (2027-2032)
- 9.3.3 China Women's Health Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Women's Health Market Size (2021-2032)
- 10.2 Asia Women's Health Market Size by Type
- 10.2.1 Asia Women's Health Market Size by Type (2021-2026)
- 10.2.2 Asia Women's Health Market Size by Type (2027-2032)
- 10.2.3 Asia Women's Health Market Share by Type (2021-2032)
- 10.3 Asia Women's Health Market Size by Application
- 10.3.1 Asia Women's Health Market Size by Application (2021-2026)
- 10.3.2 Asia Women's Health Market Size by Application (2027-2032)
- 10.3.3 Asia Women's Health Market Share by Application (2021-2032)
- 10.4 Asia Women's Health Market Size by Country
- 10.4.1 Asia Women's Health Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Women's Health Market Size by Country (2021-2026)
- 10.4.3 Asia Women's Health Market Size by Country (2027-2032)
- 10.4.4 Asia Women's Health Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Women's Health Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Women's Health Market Size by Type
- 11.2.1 South America, Middle East & Africa Women's Health Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Women's Health Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Women's Health Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Women's Health Market Size by Application
- 11.3.1 South America, Middle East & Africa Women's Health Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Women's Health Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Women's Health Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Women's Health Market Size by Country
- 11.4.1 South America, Middle East & Africa Women's Health Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Women's Health Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Women's Health Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Women's Health Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst